Glycogen synthase kinase 3␤ (GSK3␤) was originally identified as a regulator for glycogen metabolism and is now an important therapeutic target for a variety of brain disorders including neurodegenerative diseases due to it's pivotal role in cellular metabolism, proliferation and differentiation. In the development of stroke therapies focusing on tissue repair and functional recovery, promoting neurogenesis is a main approach in regenerative medicine. In the present investigation, we explored the effects of a GSK3␤ specific inhibitor, 6-Bromoindirubin-3 -oxime (BIO), on regenerative activities of neuroblasts in the subventricular zone (SVZ) and functional recovery after focal cerebral ischemia. Adult C57/BL mice were subjected to occlusion of distal branches of middle cerebral artery (MCA) supplying the sensorimotor barrel cortex. Three days later, BIO (8.5 g/kg, i.p.) was administered every 2 days until sacrificed at 14 or 21 days after stroke. The BIO treatment significantly increased generation of neuroblasts labeled with BrdU and BrdU/doublecortin (DCX) in the SVZ. Comparing to vehicle controls, increased number of neuroblasts migrated to the peri-infarct region where they differentiate into mature neurons. Along with the elevated BDNF expression at the peri-infarct area, the number of newly formed neurons was significantly increased. BIO treatment significantly enhanced sensorimotor functional recovery after the focal ischemia. It is suggested that the GSK3 signaling may be a potential therapeutic target for regenerative treatment after ischemic stroke.
a b s t r a c t
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Introduction
Stroke possesses serious threat on human life and health. Neuroprotective treatments of stroke have so far failed in clinical translation. Recent demonstrations on the existence of neurogenesis in the adult brain have implicated a potential regenerative therapy after stroke. Neurogenesis persists in the adult mammalian brain mainly in two restricted areas, the subventricular zone (SVZ) of the lateral ventricles and the dentate gyrus of the hippocampus (Woodgett, 1990) . Newly generated neural stem cells and neurobAbbreviations: BIO, 6-Bromoindirubin-3 -oxime; CCA, common carotid artery; i.p., intraperitoneal; BrdU, 5-bromo-2 -deoxyuridine; DCX, doublecortin; NeuN, neuronal nuclei; BDNF, brain derived neurotrophic factor; SVZ, sub-ventricular zone; MCA, middle cerebral artery; CCA, common carotid arteries.
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lasts at the SVZ normally migrate to the olfactory bulb (OB) through the rostral migratory stream (RMS), where they can differentiate into interneurons (Lois et al., 1996) . Neurogenesis may also contribute to tissue repair and recovery after brain injuries (Scafidi et al., 2009) . Previous findings have shown that, in the ischemic brain cell proliferation in the SVZ is augmented and, in response to the chemoattractant cues, newly generated cells can migrate to the ischemic cortex and other sub-cortical regions via the striatum route (Arvidsson et al., 2002) . Hypoxia and ischemia also may stimulate neuronal differentiation and neurite outgrowth (Wang et al., 2015) . However, newly formed neural progenitor cells in the ischemic brain have limited contribution to brain repair after injury due to significant cell death, inadequate migration/homing ability and insufficient regenerative activity of these cells. To overcome this dilemma, treatments with exogenous factors have been explored to promote the endogenous regenerative mechanism. Glycogen synthase kinase-3␤ (GSK3␤) is widely expressed in all tissues with particularly abundant levels in the brain (Woodgett, 1990) . A great number of studies indicates that GSK3␤ acts as a http://dx.doi.org/10.1016/j.ijdevneu.2017.01.002 0736-5748/© 2017 ISDN. Published by Elsevier Ltd. All rights reserved.
